
Click on each section you wish to purchase
Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Executive Summary
Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016
Summary
GlobalData's Medical Devices sector report, "Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016" provides an overview of Peripheral Transluminal Coronary Angioplasty Balloons currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Transluminal Coronary Angioplasty Balloons pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Peripheral Transluminal Coronary Angioplasty Balloons under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Transluminal Coronary Angioplasty Balloons and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Transluminal Coronary Angioplasty Balloons under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Peripheral Transluminal Coronary Angioplasty Balloons Overview 8
3 Products under Development 9
3.1 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9
3.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10
3.3 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11
3.4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12
3.5 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13
3.6 Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14
4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products under Development by Companies 15
4.1 PTCA Balloons Companies - Pipeline Products by Stage of Development 15
4.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 17
5 Peripheral Transluminal Coronary Angioplasty Balloons Companies and Product Overview 19
5.1 Aachen Resonance GmbH Company Overview 19
5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Acrostak (Schweiz) AG Company Overview 20
5.2.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 AlviMedica Medical Technologies Inc. Company Overview 21
5.3.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Andramed GmbH Company Overview 24
5.4.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Atrium Medical Corporation Company Overview 25
5.5.1 Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Bolton Medical, Inc. Company Overview 26
5.6.1 Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Boston Scientific Corporation Company Overview 29
5.7.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Cordis Corporation Company Overview 32
5.8.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Hatch Medical, L.L.C. Company Overview 34
5.9.1 Hatch Medical, L.L.C. Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Innovia LLC Company Overview 35
5.10.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Lithotech Medical Ltd. Company Overview 36
5.11.1 Lithotech Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 M.A. Med Alliance SA Company Overview 37
5.12.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 Medinol Ltd. Company Overview 38
5.13.1 Medinol Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 Medtronic plc Company Overview 40
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 Meril Life Sciences Pvt. Ltd. Company Overview 42
5.15.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 42
5.16 MicroPort Scientific Corporation Company Overview 44
5.16.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
5.17 Natec Medical Ltd Company Overview 47
5.17.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
5.18 Pressure Products, Inc. Company Overview 48
5.18.1 Pressure Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.19 QT Vascular Ltd. Company Overview 49
5.19.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
5.20 QualiMed Innovative Medizinprodukte GmbH Company Overview 55
5.20.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 55
5.21 Revma, Inc. Company Overview 56
5.21.1 Revma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.22 The Spectranetics Corporation Company Overview 57
5.22.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
5.23 TissueGen, Inc. Company Overview 59
5.23.1 TissueGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.24 VasoTech Inc. Company Overview 61
5.24.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
6 Peripheral Transluminal Coronary Angioplasty Balloons- Recent Developments 62
6.1 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 62
6.2 Aug 30, 2016: MPSC Announces 2016 Interim Results 63
6.3 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 64
6.4 Aug 22, 2016: Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group 66
6.5 Aug 22, 2016: Joacim Lindoff appointed Acting President & CEO of Getinge Group 67
6.6 Aug 10, 2016: Spectranetics Receives CE Mark for AngioSculptX 67
6.7 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 67
6.8 Jul 28, 2016: Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million 70
6.9 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 71
6.10 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 72
6.11 Jul 25, 2016: QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment 74
6.12 Jul 21, 2016: Firefighter PTCA Balloon Dilatation Catheter Granted CE Mark 74
6.13 Jul 21, 2016: Federal Circuit Court Rules in Appeal 75
6.14 Jul 14, 2016: Getinge Interim Report January-June 2016 75
6.15 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 75
6.16 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 76
6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 76
6.18 Jun 27, 2016: QT Vascular Receives FDA 510(k) Clearance For Chocolate XD, A Novel PTCA Balloon 77
6.19 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 77
6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 78
6.21 Jun 03, 2016: Getinge Group appoints Jens Viebke as new President of Acute Care Therapies Business Category Unit 78
6.22 Jun 03, 2016: LEPUCARE established in India 79
6.23 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 79
6.24 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project" 82
6.25 Mar 29, 2016: Getinge Group Receives Innovative Technology Designation from Novation for the Maquet InterValve V8 Balloon Aortic Valvuloplasty Catheter 82
6.26 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 83
6.27 Feb 29, 2016: FOXTROT PRO Gains Market Approval in Indonesia 83
6.28 Feb 25, 2016: Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million 83
6.29 Feb 23, 2016: Lepu Medical Amends Private Placement of Shares for USD110 Million 84
6.30 Feb 11, 2016: QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore 84
6.31 Feb 10, 2016: QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore 85
6.32 Feb 01, 2016: TE Connectivity to Acquire Creganna Medical from Permira Advisers for USD895 Million 85
6.33 Jan 21, 2016: NC Tadpole Obtained CFDA Registration Certificate 86
6.34 Jan 05, 2016: QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon 86
6.35 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 87
6.36 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment 87
6.37 Dec 17, 2015: OrbusNeich demonstrates Sapphire II Coronary Dilatation Catheter at GulfPCR-GIM 2015 88
6.38 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 88
6.39 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group of High-tech Enterprise 90
6.40 Nov 18, 2015: Major Expansion for Creganna Medical, Minnesota 90
6.41 Oct 28, 2015: CITIC Private Equity Funds Management to Acquire Biosensors International 91
7 Appendix 92
7.1 Methodology 92
7.2 About GlobalData 94
7.3 Contact Us 94
7.4 Disclaimer 95
1.2 List of Figures
Figure 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9
Figure 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10
Figure 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11
Figure 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12
Figure 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13
Figure 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14
1.1 List of Tables
Table 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9
Table 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10
Table 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11
Table 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12
Table 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13
Table 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14
Table 7: Peripheral Transluminal Coronary Angioplasty Balloons Companies - Pipeline Products by Stage of Development 15
Table 8: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 17
Table 9: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
Table 10: VIAR - Product Status 19
Table 11: VIAR - Product Description 19
Table 12: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 20
Table 13: PTCA Balloon - Product Status 20
Table 14: PTCA Balloon - Product Description 20
Table 15: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 16: Pegaso Aria - Product Status 21
Table 17: Pegaso Aria - Product Description 22
Table 18: Pegaso Brio - Product Status 22
Table 19: Pegaso Brio - Product Description 22
Table 20: ProHP - Product Status 23
Table 21: ProHP - Product Description 23
Table 22: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 24
Table 23: Zero-Profile PTCA Balloon - Product Status 24
Table 24: Zero-Profile PTCA Balloon - Product Description 24
Table 25: Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
Table 26: Coronary Stent Balloon Catheter - Product Status 25
Table 27: Coronary Stent Balloon Catheter - Product Description 25
Table 28: Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 29: Flash PTCA - Product Status 26
Table 30: Flash PTCA - Product Description 26
Table 31: Runner PTCA Balloon Catheter - Product Status 27
Table 32: Runner PTCA Balloon Catheter - Product Description 27
Table 33: Runner Slim PTCA - Product Status 28
Table 34: Runner Slim PTCA - Product Description 28
Table 35: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
Table 36: 1.2 Zulu PTCA - Product Status 29
Table 37: 1.2 Zulu PTCA - Product Description 30
Table 38: NC Zulu PTCA Post-Dilatation Catheter - Product Status 30
Table 39: NC Zulu PTCA Post-Dilatation Catheter - Product Description 30
Table 40: Zulu PTCA Pre-Dilatation Catheter - Product Status 31
Table 41: Zulu PTCA Pre-Dilatation Catheter - Product Description 31
Table 42: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: Next Generation EMPIRA PTCA Balloon - Product Status 32
Table 44: Next Generation EMPIRA PTCA Balloon - Product Description 33
Table 45: Hatch Medical, L.L.C. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 46: Hydra Bifurcated Coronary Balloon Catheter - Product Status 34
Table 47: Hydra Bifurcated Coronary Balloon Catheter - Product Description 34
Table 48: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 49: Low Profile Angioplasty Balloon Catheter - Product Status 35
Table 50: Low Profile Angioplasty Balloon Catheter - Product Description 35
Table 51: Lithotech Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 52: Scoring Balloon - Product Status 36
Table 53: Scoring Balloon - Product Description 36
Table 54: M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 37
Table 55: SELUTION Sirolimus Coated Balloon - Product Status 37
Table 56: SELUTION Sirolimus Coated Balloon - Product Description 37
Table 57: Medinol Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 58: Gallant PTCA Balloon Catheter - Product Status 38
Table 59: Gallant PTCA Balloon Catheter - Product Description 39
Table 60: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 61: Euphora Drug Coated Balloon - Product Status 40
Table 62: Euphora Drug Coated Balloon - Product Description 41
Table 63: Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 64: Mozec-Rx PTCA Balloon Dilatation Catheter - Product Status 42
Table 65: Mozec-Rx PTCA Balloon Dilatation Catheter - Product Description 43
Table 66: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
Table 67: Hercules-D - Product Status 44
Table 68: Hercules-D - Product Description 45
Table 69: Ryfle PTCA Balloon - Product Status 45
Table 70: Ryfle PTCA Balloon - Product Description 45
Table 71: Ryfle PTCA Balloon Catheter - Product Status 46
Table 72: Ryfle PTCA Balloon Catheter - Product Description 46
Table 73: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Table 74: NATEC Angioplasty Balloon - Product Status 47
Table 75: NATEC Angioplasty Balloon - Product Description 47
Table 76: Pressure Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 77: SafeVue Balloon Catheter - Product Status 48
Table 78: SafeVue Balloon Catheter - Product Description 48
Table 79: QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 80: Chocolate Heart - Product Status 49
Table 81: Chocolate Heart - Product Description 50
Table 82: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Status 50
Table 83: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Description 50
Table 84: Silk PTCA Balloon Catheter - Product Status 51
Table 85: Silk PTCA Balloon Catheter - Product Description 51
Table 86: QT Vascular Ltd. - Ongoing Clinical Trials Overview 52
Table 87: Chocolate Touch PTCA Coronary Drug Coated Balloon - Clinical Study Evaluating the Chocolate Touch PTCA Coronary Drug-coated Balloon 53
Table 88: Chocolate Heart - A Feasibility Study of Chocolate Heart Drug Coated Coronary Balloon in De novo Lesions 54
Table 89: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 55
Table 90: Biodegradable Balloon - Product Status 55
Table 91: Biodegradable Balloon - Product Description 55
Table 92: Revma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
Table 93: Coronary Post-Dilatation Catheter - Product Status 56
Table 94: Coronary Post-Dilatation Catheter - Product Description 56
Table 95: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
Table 96: CardioSculpt Valvuloplasty Scoring Balloon - Product Status 57
Table 97: CardioSculpt Valvuloplasty Scoring Balloon - Product Description 58
Table 98: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status 58
Table 99: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description 58
Table 100: TissueGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 101: Anti-arrhythmia OTW Device - Product Status 59
Table 102: Anti-arrhythmia OTW Device - Product Description 60
Table 103: VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 104: DirectBalloon - Product Status 61
Table 105: DirectBalloon - Product Description 61
Table 106: Glossary 93
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Aachen Resonance GmbH
Acrostak (Schweiz) AG
AlviMedica Medical Technologies Inc.
Andramed GmbH
Atrium Medical Corporation
Bolton Medical, Inc.
Boston Scientific Corporation
Cordis Corporation
Hatch Medical, L.L.C.
Innovia LLC
Lithotech Medical Ltd.
M.A. Med Alliance SA
Medinol Ltd.
Medtronic plc
Meril Life Sciences Pvt. Ltd.
MicroPort Scientific Corporation
Natec Medical Ltd
Pressure Products, Inc.
QT Vascular Ltd.
QualiMed Innovative Medizinprodukte GmbH
Revma, Inc.
The Spectranetics Corporation
TissueGen, Inc.
VasoTech Inc.
For Regular updates on our latest research reports
Compare